NCT02970799View on ClinicalTrials.gov

Tear Production by Nasal Neurostimulation Compared to Active Control

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Dry EyeDry Eye SyndromesKeratoconjunctivitis Sicca
Interventions
DEVICE

Intranasal Neurostimulator

The device delivers small electrical currents, activating nerves that stimulate the body's natural tear production system.

Sponsors

Lead Sponsor

Oculeve, Inc.
All Listed Sponsors
lead

Oculeve, Inc.

INDUSTRY